Linda completed her PhD in stem cell biology and hematopoietic development from Harvard Medical School. Her research is focused on harnessing the regenerative potential of human pluripotent stem cells to generate antigen-specific T cells de novo, which will inform novel experimental and therapeutic strategies for cancer immunotherapy and autoimmunity. Linda is a recipient of the Damon Runyon Postdoctoral Research Fellowship.